Continuous positive airway pressure (CPAP) for acute bronchiolitis in children

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 6, 2015, Pages

  Jat, Kana R ^a   Mathew, Joseph L ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; BREATHING RATE; BRONCHITIS; CARBON DIOXIDE TENSION; CLINICAL EFFECTIVENESS; EMERGENCY WARD; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; OXYGEN TENSION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; BLOOD; BRONCHIOLITIS; INFANT; META ANALYSIS; NEWBORN; PARTIAL PRESSURE; PROCEDURES; SELECTION BIAS; STATISTICS AND NUMERICAL DATA;

CARBON DIOXIDE; OXYGEN;

ACUTE DISEASE; BRONCHIOLITIS; CARBON DIOXIDE; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; OXYGEN; PARTIAL PRESSURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; SELECTION BIAS;

EID: 85017402472     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010473.pub2     Document Type: Review

References (49)

1. Milési C, Matecki S, Jaber S, Mura T, Jacquot A, Pidoux O, et al. 6 cmH2O continuous positive airway pressure versus conventional oxygen therapy in severe viral bronchiolitis: a randomized trial. Pediatric Pulmonology 2013;48:45-51.
2. Thia LP, McKenzie SA, Blyth TP, Minasian CC, Kozlowska WJ, Carr SB. Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis. Archives of Disease in Childhood 2008;93:45-7.
3. Balanzat AMC, Lazarte G, Surarez V, Bonilla ME, Gighi M, Chede C, et al. Effects of different levels of nasal continuous positive airways pressure (CPAP) in infants with severe acute bronchiolitis. European Respiratory Journal 2006;Suppl 50:P1531.
4. Chidini G, Piastra M, Wolfler A, Marchesi T, Calderini E, Conti G, et al. Noninvasive continuous positive airway pressure (NCPAP) by helmet versus facial mask: a multicenter RCT. Intensive Care Medicine 2011;Suppl 2:331-2.
5. Hough JL, Pham TMT, Schibler A. Delivery of high flow nasal prong oxygen: the effect CPAP exposed. Pediatric Critical Care Medicine 2011;3:A7.
6. Javouhey E, Barats A, Richard N, Stamm D, Floret D. Non-invasive ventilation as primary ventilatory support for infants with severe bronchiolitis. Intensive Care Medicine 2008;34:1608-14.
7. Smith PG, el-Khatib MF, Carlo WA. PEEP does not improve pulmonary mechanics in infants with bronchiolitis. American Review of Respiratory Disease 1993;147:1295-8.
8. Yañez LJ, Yunge M, Emilfork M, Lapadula M, Alcántara A, Fernández C, et al. A prospective, randomized, controlled trial of noninvasive ventilation in pediatric acute respiratory failure. Pediatric Critical Care Medicine 2008;9:484-9.
9. Beasley JM, Jones SE. Continuous positive airway pressure in bronchiolitis. BMJ 1981;283(6305):1506-8.
10. Beggs S, Wong ZH, Kaul S, Ogden KJ, Walters JE. High-flow nasal cannula therapy for infants with bronchiolitis. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD009609.pub2]
11. Cambonie G, Milési C, Jaber S, Amsallem F, Barbotte E, Picaud JC, et al. Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe acute viral bronchiolitis. Intensive Care Medicine 2008;34:1865-72.
12. Centers for Disease Control and Prevention. Respiratory syncytial virus. http://www.cdc.gov/rsv/ (accessed 13 July 2012) 2010.
13. Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatric Critical Care Medicine 2004;5(5):482-9.
14. de Bie HMA, van Toledo-Epping L, Verbeke J, van Elburg RM. Neonatal pneumatocele as a complication of nasal continuous positive airway pressure. Archives of Disease in Childhood. Fetal and Neonatal Edition 2002;86(3):F202-3.
15. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Archives of Disease in Childhood 2003;88:1065-9.
16. Donlan M, Fontela PS, Puligandla PS. Use of continuous positive airway pressure (CPAP) in acute viral bronchiolitis: a systematic review. Pediatric Pulmonology 2011;46:736-46.
17. Duncan AW, Oh TE, Hillman DR. PEEP and CPAP. Anaesthesia and Intensive Care 1986;14(3):236-50.
18. Essouri S, Durand P, Chevret L, Balu L, Devictor D, Fauroux B, et al. Optimal level of nasal continuous positive airway pressure in severe viral bronchiolitis. Intensive Care Medicine 2011;37:2002-7.
19. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD004878.pub4]
20. Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD001266.pub3]
21. GRADE Working Group. Version available at: http://ims.cochrane.org/revman/other-resources/gradepro/download. GRADEprofiler Version 3.2.2. GRADE Working Group. Version available at: http://ims.cochrane.org/revman/other-resources/gradepro/download, 2008.
22. Handforth J, Friedland JS, Sharland M. Basic epidemiology and immunopathology of RSV in children. Paediatric Respiratory Reviews 2000;1:210-4.
23. Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Epinephrine for bronchiolitis. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD003123.pub3]
24. Hartling L, Fernandes RM, Bialy L, Milne A, Johnson D, Plint A, et al. Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ 2011;342:d1714.
25. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
26. Kabir ML, Haq N, Hoque M, Ahmed F, Amin R, Hossain A, et al. Evaluation of hospitalized infants and young children with bronchiolitis - a multi centre study. Mymensingh Medical Journal 2003;12(2):128-33.
27. Kiciman NM, Andréasson B, Bernstein G, Mannino FL, Rich W, Henderson C, et al. Thoracoabdominal motion in newborns during ventilation delivered by endotracheal tube or nasal prongs. Pediatric Pulmonology 1998;25(3):175-81.
28. Larrar S, Essouri S, Durand P, Chevret L, Haas V, ChabernaudJL, et al. Effects of nasal continuous positive airway pressure ventilation in infants with severe acute bronchiolitis. Archives of Pediatrics 2006;13:1397-403.
29. Lee S-Y, Lopez V. Physiological effects of two temperature settings in preterm infants on nasal continuous airway pressure ventilation. Journal of Clinical Nursing 2002;11(6):845-7.
30. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
31. Levy BT, Graber MA. Respiratory syncytial virus infection in infants and young children. Journal of Family Practice 1997;45(6):473-81.
32. Liet J-M, Ducruet T, Gupta V, Cambonie G. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD006915.pub2]
33. McNamara F, Sullivan CE. Nasal CPAP treatment in an infant with respiratory syncytial virus-associated apnea. Pediatric Pulmonology 1997;24:218-21.
34. Meates-Dennis M. Bronchiolitis. Archives of Disease in Childhood. Education & Practice Edition 2005;90(4):ep81-6.
35. Meissner HC, Bocchini JA. Reducing RSV hospitalizations * AAP modifies recommendations for use of palivizumab in high-risk infants, young children. American Academy of Pediatrics News 2009;30(7):1-1.
36. Merkus PJ, de Hoog M, van Gent R, de Jongste JC. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis. European Respiratory Journal 2001;18(4):734-7.
37. Nasr SZ, Strouse PJ, Soskolne E, Maxvold NJ, Garver KA, Rubin BK, et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest 2001;120(1):203-8.
38. Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. Journal of Pediatrics 1992;121(3):348-54.
39. Phelan PD, Williams HE, Freeman M. The disturbances of ventilation in acute viral bronchiolitis. Journal of Paediatrics and Child Health 1968;4(2):96-104.
40. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
41. Robertson NJ, McCarthy LS, Hamilton PA, Moss AL. Nasal deformities resulting from flow driver continuous positive airway pressure. Archives of Disease in Childhood 1996;75(3):F209-12.
42. Roqué i Figuls M, Giné-Garriga M, Granados RC, Perrotta C. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD004873.pub4]
43. Soong W-J, Hwang B, Tang R-B. Continuous positive airway pressure by nasal prongs in bronchiolitis. Pediatric Pulmonology 1993;16(3):163-6.
44. Spurling GKP, Doust J, Del Mar CB, Eriksson L. Antibiotics for bronchiolitis in children. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD005189.pub3]
45. Umoren R, Odey F, Meremikwu MM. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD006435.pub2]
46. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD000181.pub3]
47. Wohl MEB, Stigol LC, Mead J. Resistance of the total respiratory system in healthy infants and infants with bronchiolitis. Pediatrics 1969;43(4):495-509.
48. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD006458.pub3]
49. Jat KR, Mathew JL. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD010473]